Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPalpha. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted